<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Tokyo_Tech_Project_Apple_Reporter"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Tokyo_Tech/Project/Apple_Reporter">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Tokyo_Tech/Project/Apple_Reporter&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Tokyo_Tech/Project/Apple_Reporter&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Tokyo_Tech/Project/Apple_Reporter&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Tokyo_Tech/Project/Apple_Reporter" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Tokyo Tech/Project/Apple Reporter</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2010.igem.org</H3><P><TITLE>
       iGEM Tokyo Tech 2010 &quot;E.coli with Humanity&quot;
       </TITLE></P><DIV id="main_wrapper"><DIV id="header"><DIV id="navigation"><DIV id="menu" style="position:static"><UL><LI id="mainHome"><A class="aMain" href="https://2010.igem.org/Team:Tokyo_Tech">Home</A></LI><LI id="mainProject"><A class="aProject">Project menu</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech">1 Graphic abstract</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech#Apple repotrers">2 Apple Reporter</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter">   2-1 Color</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter2">   2-2 Fragrance</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System">3 Artificial Cooperation System</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/lux_act_rep">   3-1 lux activation/repression part</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/Cm_assay">   3-2 Resistance gene activaion device</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/luxI_assay">   3-3 luxI Assay</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/modeling">   3-4 Modeling</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/wolf_coli">4 wolfcoli</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/wolf_coli/New_Series_of_PompC">   4-1 PompC</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/wolf_coli/lacIM1">   4-2 lacIM1</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Project/wolf_coli/System">   4-3 wolfcoli system</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Acknowledgement">Acknowledgements</A></LI></UL><LI id="mainParts"><A class="aParts" href="https://2010.igem.org/Team:Tokyo_Tech/Parts">Parts</A></LI><LI id="mainModeling"><A class="aModeling" href="https://2010.igem.org/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/modeling">Modeling</A></LI><LI id="mainTeam"><A class="aTeam" href="https://2010.igem.org/Team:Tokyo_Tech/Team">Team</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Team">Overview</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Team#Students">Students</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Team#Faculty Instructors">Faculty Instructors</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Team_history">Previous Tokyo Tech Teams</A></LI><LI id="mainSponsors"><A class="aSponsors" href="https://2010.igem.org/Team:Tokyo_Tech/Sponsors">Sponsors</A></LI><LI id="mainProject"><A class="aCriteria">For judging form</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Parts">Parts</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/safety">Safety</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Collaboration">Collaboration</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Attribution_contributions">Attribution and Contributions</A></LI><LI><A href="https://2010.igem.org/Team:Tokyo_Tech/Comments">Comments</A></LI><LI id="mainSitemap"><A class="aSitemap" href="https://2010.igem.org/Team:Tokyo_Tech/Project">Sitemap</A></LI></DIV></DIV></DIV></DIV><DIV id="super_main_wrapper"><DIV id="tf_menu"><FONT size="5" color="#eb8300"><CENTER><B>Project menu</B></CENTER></FONT><CENTER><TABLE id="table-01"><TBODY><TR><TD><A href="/Team:Tokyo_Tech" title="Team:Tokyo Tech">1 Graphic abstract</A></TD></TR><TR><TH>2 Apple reporter<DL><DD>2-1 Color  -YOU ARE HERE!-
</DD><DD><A href="/Team:Tokyo_Tech/Project/Apple_Reporter2" title="Team:Tokyo Tech/Project/Apple Reporter2">2-2 Fragrance</A></DD></DL></TH></TR><TR><TD><A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System" title="Team:Tokyo Tech/Project/Artificial Cooperation System">3 Artificial Cooperation System</A><DL><DD><A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/lux_act_rep" title="Team:Tokyo Tech/Project/Artificial Cooperation System/lux act rep">3-1 <I>lux</I> activation/repression promoter</A></DD><DD><A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/Cm_assay" title="Team:Tokyo Tech/Project/Artificial Cooperation System/Cm assay">3-2 resistance gene activation device</A></DD><DD><A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/luxI_assay" title="Team:Tokyo Tech/Project/Artificial Cooperation System/luxI assay">3-3 <I>lux</I>I Assay</A></DD><DD><A href="/Team:Tokyo_Tech/Project/Artificial_Cooperation_System/modeling" title="Team:Tokyo Tech/Project/Artificial Cooperation System/modeling">3-4 modeling</A></DD></DL></TD></TR><TR><TD><A href="/Team:Tokyo_Tech/Project/wolf_coli" title="Team:Tokyo Tech/Project/wolf coli">4 wolfcoli overview</A><DL><DD><A href="/Team:Tokyo_Tech/Project/wolf_coli/New_Series_of_PompC" title="Team:Tokyo Tech/Project/wolf coli/New Series of PompC">4-1 New series of P<I>ompC</I></A></DD><DD><A href="/Team:Tokyo_Tech/Project/wolf_coli/lacIM1" title="Team:Tokyo Tech/Project/wolf coli/lacIM1">4-2 lacIM1 for band-detect network </A></DD><DD><A href="/Team:Tokyo_Tech/Project/wolf_coli/System" title="Team:Tokyo Tech/Project/wolf coli/System">4-3 Wolf coli system</A></DD></DL></TD></TR></TBODY></TABLE></CENTER></DIV><DIV id="tf_SubWrapper"><P><FONT size="5"><B>2-1 Color</B></FONT></P><TABLE id="toc" class="toc"><TBODY><TR><TD><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Abstract"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Abstract</SPAN></A></LI><LI class="toclevel-1 tocsection-2"><A href="#Introduction"><SPAN class="tocnumber">2</SPAN><SPAN class="toctext">Introduction</SPAN></A></LI><LI class="toclevel-1 tocsection-3"><A href="#Results"><SPAN class="tocnumber">3</SPAN><SPAN class="toctext">Results</SPAN></A></LI><LI class="toclevel-2 tocsection-4"><A href="#.CE.B2-carotene_synthesis"><SPAN class="tocnumber">3.1</SPAN><SPAN class="toctext">β-carotene synthesis</SPAN></A></LI><LI class="toclevel-2 tocsection-5"><A href="#zeaxanthin_synthesis"><SPAN class="tocnumber">3.2</SPAN><SPAN class="toctext">zeaxanthin synthesis</SPAN></A></LI><LI class="toclevel-2 tocsection-6"><A href="#astaxanthin_synthesis"><SPAN class="tocnumber">3.3</SPAN><SPAN class="toctext">astaxanthin synthesis</SPAN></A></LI></UL><LI class="toclevel-1 tocsection-7"><A href="#Reference"><SPAN class="tocnumber">4</SPAN><SPAN class="toctext">Reference</SPAN></A></LI><LI class="toclevel-1 tocsection-8"><A href="#appendix"><SPAN class="tocnumber">5</SPAN><SPAN class="toctext">appendix</SPAN></A></LI><LI class="toclevel-2 tocsection-9"><A href="#.CE.B2-carotene_synthesis_2"><SPAN class="tocnumber">5.1</SPAN><SPAN class="toctext">β-carotene synthesis</SPAN></A></LI><LI class="toclevel-1 tocsection-10"><A href="#Materials_and_Methods"><SPAN class="tocnumber">6</SPAN><SPAN class="toctext">Materials and Methods</SPAN></A></LI><LI class="toclevel-2 tocsection-11"><A href="#The_work_flow_to_TLC_from_culture.5B3.5D.2C.5B4.5D"><SPAN class="tocnumber">6.1</SPAN><SPAN class="toctext">The work flow to TLC from culture[3],[4]</SPAN></A></LI><LI class="toclevel-3 tocsection-12"><A href="#Material"><SPAN class="tocnumber">6.1.1</SPAN><SPAN class="toctext">Material</SPAN></A></LI><LI class="toclevel-3 tocsection-13"><A href="#culture"><SPAN class="tocnumber">6.1.2</SPAN><SPAN class="toctext">culture</SPAN></A></LI><LI class="toclevel-3 tocsection-14"><A href="#gathering_E._coli_and_extract_pigment"><SPAN class="tocnumber">6.1.3</SPAN><SPAN class="toctext">gathering E. coli and extract pigment</SPAN></A></LI><LI class="toclevel-3 tocsection-15"><A href="#vacuum_and_concentrate"><SPAN class="tocnumber">6.1.4</SPAN><SPAN class="toctext">vacuum and concentrate</SPAN></A></LI><LI class="toclevel-3 tocsection-16"><A href="#TLC"><SPAN class="tocnumber">6.1.5</SPAN><SPAN class="toctext">TLC</SPAN></A></LI></TD></TR></TBODY></TABLE><H2><SPAN class="mw-headline" id="Abstract">Abstract</SPAN></H2><P>Our team synthesized β-carotene, zeaxanthin and astaxanthin under several conditions (strain, plasmid copy number,…etc) to confirm the functions of BioBrick parts designed by previous iGEM teams. Particularly, <B>astaxanthin is the final metabolite of the carotenoid synthetic pathway.</B></P><P>We synthesized β-carotene and zeaxanthin by assembling <I>crtEBIY</I> and <I>crtZ</I> of existing BioBrick parts. <B>Though the part <I>crtZ</I> has been unconfirmed to produce zeaxanthin, we confirmed it for the first time in iGEM.</B></P><P>In addition, we succeeded in synthesizing astaxanthin by introducing <B>the new BioBrick part  <I>crtW</I></B>. Therefore, the carotenoid synthetic pathway reached the end.
</P><DIV class="thumb tleft"><DIV class="thumbinner" style="width:392px;"><DIV class="thumbcaption">Fig. 2-1-1. carotenoid synthetic pathway</DIV></DIV></DIV><DIV class="thumb tright"><DIV class="thumbinner" style="width:212px;"><DIV class="thumbcaption">Fig.2-1-2.TLC  worked by Yumiko Kinoshita</DIV></DIV></DIV><P><A href="https://2010.igem.org/Team:Tokyo_Tech/Parts" class="external text" rel="nofollow">→our BioBrick parts</A><A href="http://partsregistry.org/Part:BBa_K395704" class="external text" rel="nofollow">→BBa_395704</A><A href="http://partsregistry.org/Part:BBa_K395706" class="external text" rel="nofollow">→BBa_395706</A></P><H2><SPAN class="mw-headline" id="Introduction">Introduction</SPAN></H2><P>Carotenoids are natural organic pigments in plants and bacteria. Synthetic carotenoid pigments colored yellow, red or orange represent about 15-25% of the cost of production of commercial feed. Carotenoids are terpenoid based on a structure having the chemical formula C<SUB>40</SUB>H<SUB>56</SUB>. There are about 600 carotenoids, which perform a wide range of functions. (For example, acting as antioxidants<A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter#Reference" class="external autonumber" rel="nofollow">[1]</A>, and as precursors to other organic compounds.) <B>Among carotenoids, astaxanthin is not known to be converted to Vitamin A, which is converted from most of carotenoids and is toxic when its concentration too high.</B></P><P>Previous year, our team has completed melanin synthetic pathway. Since the carotenoid synthetic pathway is huge, BioBrick Registry doesn’t cover all parts to complete the pathway. <B>This year, we introduced a new BioBrick part to synthesize more various kinds of carotenoids. And we succeeded in synthesizing astaxanthin, one of the final metabolite of the pathway.</B></P><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:502px;"><DIV class="thumbcaption">Fig. 2-1-3. note</DIV></DIV></DIV></DIV><H2><SPAN class="mw-headline" id="Results">Results</SPAN></H2><H3><SPAN class="mw-headline" id=".CE.B2-carotene_synthesis">β-carotene synthesis</SPAN></H3><DIV class="thumb tright"><DIV class="thumbinner" style="width:202px;"><DIV class="thumbcaption">Fig.2-1-4.β-carotene</DIV></DIV></DIV><P>Our team synthesized β-carotene under several conditions to confirm the functions of BioBrick parts designed by Cambridge 2009. (we call it &quot;crtEBIY plasmids&quot;.) (<A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter#appendix" class="external text" rel="nofollow">See more...</A>)
</P><H3><SPAN class="mw-headline" id="zeaxanthin_synthesis">zeaxanthin synthesis</SPAN></H3><DIV class="thumb tright"><DIV class="thumbinner" style="width:202px;"><DIV class="thumbcaption">Fig.2-1-5zeaxanthin</DIV></DIV></DIV><P>Our team tried to synthesize zeaxanthin by using the constructed (<A href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K395704" class="external text" rel="nofollow">BBa_K395704</A>)part to confirm the activity of BioBrick parts designed by Cambredge 2009 and Edinburgh 2007. We also confirmed zeaxanthin by TLC (Fig.2-1-6 spot III). 
</P><P>
By introduction of <I>crtZ</I> gene to the <I>crtEBIY</I> plasmid (we call this construct “single plasmid construct”, &quot;<I>crtZ-crtEBIY</I>&quot;.), new spot appered on TLC plate (Fig.2-1-6 spot III). The spot shows lower Rf value than that derived from <I>crtEBIY</I> (Fig.2-1-6 spot II).  The Rf values of spots derived from <I>crtEBIY</I> and <I>crtZ-crtEBIY</I> corresponded to reported values of β-caroten and Zeaxanthin, respectively.<A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter#Reference" class="external autonumber" rel="nofollow">[2]</A> Thus we could characterize zeaxanthin production activity of crtZ. In addition, caracterization of the part <I>crtZ</I> is the first work in iGEM. 
</P><P>
In order to maximize zeaxanthin production, we designed some combinations of construct. We thought of another type of zeaxanthin synthetic construct where <I>“crtZ”</I> (BBa_I742158) and <I>“crtEBIY”</I> (BBa_K274210) were separated on different plasmids. (we call this type of constructs “double plasmids construct.”)
</P><P>
After all, We made five combinations shown in table&lt;1&gt;, including <A href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K395701" class="external text" rel="nofollow">BBa_K395701</A>, <A href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K395702" class="external text" rel="nofollow">BBa_K395702</A> and <A href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K395704" class="external text" rel="nofollow">BBa_K395704</A>.
</P><P>
Constructs containing pBad/araC promoter on high-copy vector show the best production and double plasmids construct shows as much production as single plasmid construct under same promoter combination. Construct with pBad/araC promoter shows better production than that with plac promoter. Construct that <I>crtEBIY</I> on high-copy vector and <I>crtZ</I> on low-copy vector shows as much expression as construct that <I>crtEBIY</I> on low-copy vector and <I>crtZ</I> on high-copy vector.（Actually, 3 showed a little more production than 5.） 
</P><P>
For TLC, We selected the best three samples including the sample derived from single plasmid construct . 
</P><P>In the consequence of TLC, we could confirm that these three samples were zeaxanthin.
</P><DIV class="thumb tleft"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">S1 : zeaxanthin expression components</DIV></DIV></DIV><DIV class="thumb tright"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">Fig.2-1-6 zeaxanthin TLC  worked by Yumiko Kinoshita</DIV></DIV></DIV><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:502px;"><DIV class="thumbcaption">Fig.2-1-7 table&lt;1&gt;　 zeaxanthin  worked by Yumiko Kinoshita</DIV></DIV></DIV></DIV><H3><SPAN class="mw-headline" id="astaxanthin_synthesis">astaxanthin synthesis</SPAN></H3><DIV class="thumb tright"><DIV class="thumbinner" style="width:202px;"><DIV class="thumbcaption">Fig.2-1-8 astaxanthin</DIV></DIV></DIV><P>Our team synthesized astaxanthin for the first time in iGEM. Thus the carotenoid synthetic pathway reached the end. This work was done by assembling the new BioBrick part <I>crtW</I> and zeaxanthin synthesis constructs we designed. From the result of “zeaxanthin synthesis”, we decided to use pBad/araC promoter and double plasmids construct.
After constructing the new BioBrick device (<A href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K395706" class="external text" rel="nofollow">BBa_K395706</A>) to synthesize astaxanthin, we characterize the function under the condition I in table&lt;2&gt;.  Thus we confirmed astaxanthin by TLC (Fig2-1-6 spot IV). 
</P><P>
By introduction of <I>crtW</I> gene to the <I>crtZ</I> plasmid (the second construct of five combinations in “zeaxanthin synthesis”,having pBad/araC promoter), new spot ((Fig2-1-6 spot IV) appeared on TLC plate. The spot shows lower Rf value than that derived from <I>crtEBIY</I> (II) and a little higher Rf value than that derived from <I>crtZ-crtW</I>(III). All the Rf values of  spots corresponded to reported values  respectively.<A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter#Reference" class="external text" rel="nofollow">[2</A>] Thus we succeeded in characterizing astaxanthin production activity of <I>crtW</I>. (<A href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K395705" class="external text" rel="nofollow">BBa_K395705</A>, <A href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K395706" class="external text" rel="nofollow">BBa_K395706</A>) 
</P><P>
For the same reason as “zeaxanthin synthesis”, we examined under several conditions →table&lt;2&gt;.
</P><P>In the consequence of TLC, we could confirm that these four samples were astaxanthin.
</P><P>
Not only astaxanthin but also another spots were produced at II. 
</P><P>We regarded them as intermediary metabolites between zeaxanthin and astaxanthin.
</P><P>
The activity of pBad/araC promoter is measured in detail on another page. <A href="https://2010.igem.org/Team:Tokyo_Tech/Project/wolf_coli/lacIM1" class="external text" rel="nofollow">→click</A></P><DIV class="thumb tleft"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">S2 : astaxanthin expression component</DIV></DIV></DIV><DIV class="thumb tright"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">Fig.2-1-6 TLC astaxanthin  worked by Yumiko Kinoshita</DIV></DIV></DIV><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:502px;"><DIV class="thumbcaption">Fig.2-1-9 astaxanthin  worked by Yumiko Kinoshita</DIV></DIV></DIV></DIV><P>acetone extract and vacuum concentration <A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter#Materials_and_Methods" class="external text" rel="nofollow">→protocol</A></P><H2><SPAN class="mw-headline" id="Reference">Reference</SPAN></H2><P>[1] Yousry M. Antioxidant Activities of Astaxanthin and Related Carotenoids. J. Agric. Food Chem. 2000, 48, 1150-1154
[2]N.M. Sachindra, et al. Carotenoids in crabs from marine and fresh waters of India. LWT 38 (2005) 221–225
</P><P>[3]MISAWA N, et al. Structure and Functional Analysis of a Marine Bacterial Carotenoid Biosynthesis Gene Cluster and Astaxanthin Biosynthetic Pathway Proposed at the Gene Level. JOURNAL OF BACTERIOLOGY, Nov. 1995, p. 6575–6584 Vol. 177, No. 22
</P><P>[4]Seon-Kang C, et al. Characterization of bacterial β-carotene Ketolases, CrtW,
from Mrine Bacteria by Complementation Analysis in <I>Escherichia coli</I>. MARINE BIOTECHNOLOGY(2005) 7, 515-522
</P><P>[5]Seon-Kang C, et al. Characterization of bacterial β-carotene 3,3′-hydroxylases, CrtZ,
and P450 in astaxanthin biosynthetic pathway and adonirubin
production by gene combination in <I>Escherichia coli</I>. Appl Microbiol Biotechnol (2006) 72
</P><P>
[6]Nishizaki T, et al. Metabolic engineering of carotenoid biosynthesis in <I>Escherichia coli</I> by ordered gene assembly in Bacillus subtilis. Appl Environ Microbiol. 2007 Feb
</P><P>[7]Arunkumar K, et al. Structure of a carotenoid gene cluster from Pantoea sp. strain C1B1Y and characterization of β-carotene hydroxylase(crtZ)gene by functional complementation in <I>Escherichia coli</I>. Carotenoid Science Vol.11 (2007)
</P><H2><SPAN class="mw-headline" id="appendix">appendix</SPAN></H2><H3><SPAN class="mw-headline" id=".CE.B2-carotene_synthesis_2">β-carotene synthesis</SPAN></H3><DIV class="thumb tright"><DIV class="thumbinner" style="width:202px;"><DIV class="thumbcaption">Fig.2-1-4 β-carotene</DIV></DIV></DIV><P>Our team synthesized β-carotene under several conditions to confirm the activity of BioBrick parts designed by Cambredge 2009. 
</P><P>We used <I>crtEBIY</I> (BBa_K274210) to synthesize β-carotene. We compared the plasmids  containing pSB3K3 (low-copy vector) with the plasmids containing pSB1A2 (high-copy vector) from the production. We also introduced the low-copy plasmid into <I>E. Coli</I>   strain MG1655, JM109 and DH5α respectively. 
</P><P>We found that MG1655 and JM109 produce more β-carotene than DH5α in liquid culture and that MG1655 grow better than JM109 on plate culture. These results indicated that MG1655 is the best of the three strains to treat. For this reason, we decided to use only MG1655 to extract pigment.
</P><P>We also made special competent cell, MG1655 and JM109, having a plasmid <I>crtEBIY</I>; pSB1A2 or <I>crtEBIY</I>; pSB3K3) for zeaxanthin and astaxanthin synthesis.(→<A href="https://2010.igem.org/Image:Tokyotech_Fig._1.1.7.1.BBa_K395704.jpg" class="external text" rel="nofollow">S1</A>, <A href="https://2010.igem.org/Image:Tokyotech_Fig._2-1-10_1BBa_K395706.jpg" class="external text" rel="nofollow">S2</A>)
</P><P>
~acetone extract~
<A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter#Materials_and_Methods" class="external text" rel="nofollow">→protocol</A></P><DIV class="thumb tleft"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">Fig.2-1-10. β-carotene extract       /worked by Yumiko Kinoshita</DIV></DIV></DIV><DIV class="thumb tright"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption">Fig.2-1-11. β-carotene plate        /worked by Yumiko Kinoshita</DIV></DIV></DIV><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:202px;"><DIV class="thumbcaption">Fig.2-1-12. β-carotene table        /worked by Yumiko Kinoshita</DIV></DIV></DIV></DIV><H2><SPAN class="mw-headline" id="Materials_and_Methods">Materials and Methods</SPAN></H2><H3><SPAN class="mw-headline" id="The_work_flow_to_TLC_from_culture.5B3.5D.2C.5B4.5D">The work flow to TLC from culture<A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter#Reference" class="external autonumber" rel="nofollow">[3]</A>,<A href="https://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter#Reference" class="external autonumber" rel="nofollow">[4]</A></SPAN></H3><H4><SPAN class="mw-headline" id="Material">Material</SPAN></H4><P><I>E. coli</I> : strain MG1655 
</P><P>reagent      : acetone, methanol, chloroform, hexane
</P><P>TLC plate      : silicagel 60F<SUB>254</SUB></P><H4><SPAN class="mw-headline" id="culture">culture</SPAN></H4><P>1. The cells were cultured over night.
</P><P>2. 50ul bacterial solution was taken from culture prepared in 1 and moved into 50ml LB culture with appropriate antibiotic. Inducer was added, if necessary.
</P><P>3. The cells were incubated at 37°C, 24hour.
</P><H4><SPAN class="mw-headline" id="gathering_E._coli_and_extract_pigment">gathering <I>E. coli</I> and extract pigment</SPAN></H4><P>4. After the O.D reach 2.0, culture was centrifuged for 10minutes at 
4°C, 6000rpm,10min
</P><P>5. Supernatant was removed by decanting. The remainder was added with 1 ml ddH<SUB>2</SUB>0 and vortexed.
</P><P>6. Moved into 2ml tube by using P1000 pipetter at least twice.
</P><P>7. Solution is centrifuged for 20minutes at 4°C, 14000rpm
</P><P>8. Supernatant was removed completely using pipetter. About 100ul of pellet is obtained.
</P><P>9. Pellet is added with 500ul acetone, and vortexed for 10 minutes to extract the pigment.
</P><P>10. Solution is centrifuged for 20minutes at 4°C, 14000rpm
</P><P>11. Acetone solution was replaced into 2 ml tube.
</P><H4><SPAN class="mw-headline" id="vacuum_and_concentrate">vacuum and concentrate</SPAN></H4><P>12. Acetone was removed using rotary evaporator.
</P><P>13. 50 ul of Chloroform/Methanol(weight ratio of 9:1) solution was added.
</P><P>14. Sample was vortexed and spinned down.
</P><P>15. The water layer was removed.
</P><H4><SPAN class="mw-headline" id="TLC">TLC</SPAN></H4><P>16.  Spot the sample onto TLC silica gel plate, and developed by acetone/hexane(weight ratio of 1:3) solution.
</P>
17. Spot was observed under visible light.</DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter">http://2010.igem.org/Team:Tokyo_Tech/Project/Apple_Reporter</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Tokyo_Tech/Project/Apple_Reporter" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Tokyo_Tech/Project/Apple_Reporter" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Tokyo_Tech/Project/Apple_Reporter&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Tokyo_Tech/Project/Apple_Reporter&amp;oldid=208420" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2010.igem.org:Privacy_policy" title="2010.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2010.igem.org:General_disclaimer" title="2010.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>